English
Specials
My Feed
Moneycontrol PRO
you are here:

Amgen

SYMBOL:AMGN|SECTOR:Health Care|DERIVED:CFD
i
Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices are indicative only and not appropriate for trading purposes. Therefore Moneycontrol doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
$
5
5
5
5
.
3
3
8
8
2
2
3.45 (1.23%)

As on 23 May, 2025 | 01:29 IST

Day Range
269.10
275.59
LH
52 Week Range
253.95
346.48
LH
Advance Chart
Open271.34
Previous Close271.53
Beta0.28
High275.59
Low269.10
TTM EPS See historical trend   20.76(+11.43% YoY)
52 Week High346.48
52 Week Low253.95
TTM PE See historical trend    13.10(Low PE)
Mkt. Cap ($ Billion)146.16
Dividend Yield3.06

Advanced Chart

*Delayed by 20 seconds

MC Technicals

Technical rating
i
This represents current trend.
Click here  for disclaimer.
Trend
Very Bearish
See Details  
Historical Rating  
Moving AveragesBearish
Technical IndicatorsBearish
Moving Averages CrossoversBearish

Pivot levels

TypeR1R2R3PPS1S2S3
Classic274.11 276.69 278.44272.36 269.78 268.03 265.45
Fibonacci274.01 275.03 276.69272.36 270.71 269.68 268.03
Camarilla271.93 272.32 272.72272.36 271.13 270.74 270.34

Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

Moving Averages
Days
5273.35
10271.14
20275.91
50290.12
100288.55
200299.86

Returns

Price Performance
1 Week0.13%
1 Month
-2.32%
3 Months
-10.36%
YTD4.34%
1 Year
-12.09%
3 Years9.86%

Financialsin million $

Peers

NamePrice ($)Change%M.Cap(Billion $)TTM PETTM EPSDY52 wk high/lowTechnical Rating
Eli Lilly732.30-0.25695.17123.705.920.96746.56/0.00-13.33Neutral
J&J175.46-0.75422.3816.7310.492.88177.67/0.0012.33Neutral
AbbVie207.90-0.08366.9517.4411.924.39210.41/0.007.73Bearish
Merck83.22-1.01211.1726.933.092.5385.48/0.000.24Bearish
Amgen313.690.42163.2417.4917.423.52329.72/215.32-1.81Bearish
+ See More

Market news

Wall Street indexes end lower as jobs data fuels economic worries

September 6, 2025 10:13 AM
Show More

About the company

Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. Its marketed products portfolio includes ENBREL, Prolia (denosumab), Neulasta (pegfilgrastim), Otezla, XGEVA, Aranesp (darbepoetin alfa), KYPROLIS, Repatha (evolocumab), Nplate (romiplostim), Vectibix (panitumumab), MVASI (bevacizumab-awwb), Parsabiv (etelcalcetide), EPOGEN (epoetin alfa), KANJINTI (trastuzumab-anns), BLINCYTO (blinatumomab), Aimovig (erenumab-aooe), EVENITY (romosozumab-aqqg), AMGEVITATM (adalimumab), Sensipar/Mimpara (cinacalcet), NEUPOGEN (filgrastim), IMLYGIC (talimogene laherparepvec), Corlanor (ivabradine) and AVSOLA (infliximab-axxq). It focuses on human therapeutics for the treatment of serious illness in the areas of inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology and neuroscience.